Files

pecoul2016_2108.pdf (158.61 KB)

Document type

Article

Version

Published version

Publication date

2016-02-25

Publication license

cc by (c) Pecoul et al., 2016
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/98690

The BENEFIT Trial: Where Do We Go from Here?

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

http://dx.doi.org/10.1371/journal.pntd.0004343

Abstract

In the next five years, we can now project that 200,000 people living with Chagas disease will die from heart disease and related complications. We urgently need to redouble our efforts to identify and treat young people who are still in the early stages of their illness, but ultimately we need to find better treatments and new cures.

Subject

Malaltia de Chagas, Malalties del cor

Subject (English)

Chagas' disease, Heart diseases

Citation

Collections

Articles publicats en revistes (ISGlobal)

Citation

PECOUL, Bernard, et al. The BENEFIT Trial: Where Do We Go from Here?. PLoS Neglected Tropical Diseases. 2016. Vol. 10, num. 2, pags. e0004343. ISSN 1935-2727. [consulted: 8 of June of 2026]. Available at: https://hdl.handle.net/2445/98690

Export metadata

JSON - METS

Share record